Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Sun Pharma - For Students

Download as xlsx, pdf, or txt
Download as xlsx, pdf, or txt
You are on page 1of 7

FY ending Mar-13 Mar-14 Mar-15 Mar-16

Sales 11,131 16,080 27,392 28,487


Material Cost 2074 2779 6738 6330
Manufacturing Cost 808 1047 1989 2353
Gross Profit 8,249 12,255 18,665 19,804
Employee Cost 1535 2074 4503 4772
Other Cost 1930 3177 6268 6859
Operating Profit 4,784 7,003 7,894 8,174
Other Income -90 -1,968 283 -42
Exceptional items -478 -2,231 -57 -589
Other income normal 388 263 340 546
Interest 43 44 579 523
Depreciation 336 409 1,195 1,038
EBITDA 5,120 7,412 9,089 9,212
Profit before tax 4,315 4,581 6,403 6,571
Tax 846 702 927 913
Tax % 19.6% 15.3% 14.5% 13.9%
Net Profit 3,469 3,879 5,476 5,658
Minority share -486 -738 -936 -1,113
Profit for EPS 2,983 3,141 4,539 4,546
EPS in Rs 14.40 15.17 21.92 18.89

Margins
Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

31,578 26,489 29,066 32,838 33,498 38,654 43,886


8131 7425 7868 9231 8689 10352 10664 10664
2498 2389 2500 2312 2352 2582 2765 3395
20,949 16,675 18,698 21,295 22,457 25,720 30,457 -14,059
4901 5367 5967 6364 6864 7302 8294 9428
5946 5677 6354 7948 7123 8161 10385 11987
10,102 5,631 6,377 6,983 8,470 10,258 11,777 -35,474
610 -135 -258 382 -3,449 -3,505 333 860
37 -947 -1,263 -266 -4,292 -4,532 -164 -494
573 812 1,005 648 843 1,027 497 1,354
400 518 555 303 141 127 172 238
1,265 1,500 1,753 2,053 2,080 2,144 2,529 2,557
11,367 7,131 8,130 9,036 10,550 12,402 14,306 -32,917
9,048 3,479 3,810 5,010 2,799 4,481 9,408 11,088
1202 937 602 838 527 1092 895 1478
13.3% 26.9% 15.8% 16.7% 18.8% 24.4% 9.5% 13.3%
7,846 2,542 3,208 4,172 2,272 3,389 8,513 9,610
-882 -447 -542 -407 631 -117 -39 -34
6,964 2,096 2,665 3,765 2,904 3,273 8,474 9,576
29.03 8.73 11.11 15.69 12.10 13.64 35.32 39.91
FY ending Mar-13 Mar-14 Mar-15

Shareholder's Equity 14990 18,525 25,638


Equity Capital 104 207 207
Reserves 14,886 18,318 25,431
Total Borrowings 260 2,561 8,996
Long term Borrowings 115 49 1,368
Short term Borrowings 83 2,440 6,228
Lease Liabilities 0 0 0
Other Borrowings 62 72 1,400
Other Liabilities 5,128 8,009 14,089
Non controlling int 1,635 1,921 2,851
Trade Payables 1,058 1,328 3,287
Advance from Customers 9 10 37
Other liability items 2,426 4,750 7,914
Total Liabilities 20,377 29,095 48,723

Fixed Assets 5,647 6,817 12,682


CWIP 563 842 2,039
Investments 2,412 2,786 2,716
Other Assets 11,756 18,650 31,286
Inventories 2,578 3,123 5,668
Trade receivables 2,412 2,200 5,106
Cash Equivalents 4,059 7,590 10,998
Short term loans 315 482 51
Other asset items 2,392 5,254 9,462
Total Assets 20,377 29,095 48,723

Liquidity ratios

Leverage/Solvency Ratios

Turnover/Efficiency Ratios
Return Ratios
Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

32,983 36,640 38,314 41,409 45,265 46,463 48,011 55,995 63,667


241 240 240 240 240 240 240 240 240
32,742 36,400 38,074 41,169 45,025 46,223 47,771 55,755 63,427
8,497 9,832 10,385 10,514 8,315 3,869 1,290 6,886 3,274
3,110 1,436 1,772 1,523 2,029 655 230 0 1
5,206 6,655 7,980 8,371 5,549 2,869 701 6,198 2,844
0 0 0 0 0 345 360 688 428
180 1,741 633 621 737 0 0 0 1
13,948 14,624 15,598 12,666 14,615 17,291 20,474 17,831 18,522
4,085 3,791 3,884 3,314 3,860 3,017 3,055 3,320 3,439
3,583 4,395 4,766 4,148 3,584 3,974 4,490 5,682 5,653
72 121 30 69 53 47 29 41 0
6,208 6,317 6,918 5,135 7,118 10,253 12,901 8,788 9,430
55,428 61,095 64,297 64,590 68,194 67,622 69,776 80,712 85,463

15,872 17,675 18,853 21,837 22,847 21,553 22,665 24,420 27,458


2,175 2,801 2,465 1,411 1,220 1,567 1,287 4,973 1,108
1,830 1,192 7,143 7,903 10,143 9,612 12,849 14,830 15,026
35,550 39,427 35,837 33,439 33,984 34,890 32,975 36,489 41,872
6,423 6,833 6,881 7,886 7,875 8,997 8,925 10,513 9,868
6,776 7,203 7,815 8,884 9,421 9,061 10,485 11,439 11,249
13,182 15,141 9,929 7,276 6,488 6,446 5,033 5,770 10,521
1,123 1,071 92 310 149 58 172 188 65
8,047 9,180 11,119 9,083 10,051 10,328 8,361 8,579 10,168
55,428 61,095 64,297 64,590 68,194 67,622 69,776 80,712 85,463
FY ending Mar-13 Mar-14 Mar-15

Cash from Operating Activity 3,357 3,959 5,616


Profit from operations 4,475 4,541 7,177
Receivables -502 222 -1,046
Inventory -390 -545 190
Payables 68 272 341
Loans Advances -67 339 28
Other WC items 846 -81 667
Working capital changes -45 207 180
Direct taxes -1,073 -789 -1,740
Cash from Investing Activity -2,375 -2,176 -1,502
Fixed assets purchased -879 -906 -2,350
Fixed assets sold 14 9 50
Investments purchased -15,672 -28,265 -28,802
Investments sold 15,625 28,186 28,841
Interest received 257 194 289
Dividends received 2 4 0
Investment in group cos 0 0 0
Redemp n Canc of Shares 0 0 0
Acquisition of companies -1,641 0 0
Other investing items -81 -1,397 470
Cash from Financing Activity -665 507 -1,187
Proceeds from shares 36 18 0
Proceeds from borrowings 14 -40 1,198
Repayment of borrowings -89 0 0
Interest paid fin -38 -23 -350
Dividends paid -440 -518 -310
Financial liabilities 0 0 0
Other financing items -148 1,069 -1,724
Net Cash Flow 316 2,290 2,927
Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

6,686 7,082 3,907 2,196 6,555 6,170 8,985 4,959 12,135


8,428 9,549 4,861 5,779 7,002 4,609 6,456 12,131 12,642
-1,810 -293 -773 -858 -374 94 -1,342 -953 353
-167 -345 -4 -709 257 -1,080 307 -1,202 599
362 735 383 -854 -210 381 370 1,182 250
0 0 0 0 0 0 0 0 0
1,861 -506 182 -275 1,226 3,169 2,224 -4,689 -139
247 -409 -212 -2,696 899 2,564 1,559 -5,662 1,062
-1,988 -2,057 -742 -886 -1,346 -1,003 969 -1,510 -1,569
-3,949 -4,186 -3,104 -310 -2,225 407 -5,556 -7,220 -690
-3,404 -3,693 -1,961 -3,213 -1,542 -1,170 -1,495 -2,086 -2,202
71 102 66 50 92 97 61 21 31
-40,122 -38,831 -40,587 -35,396 -33,445 -18,542 -24,135 -21,809 -29,091
41,641 39,194 34,992 35,207 31,894 19,709 20,702 20,897 30,094
338 337 510 684 338 72 76 318 613
50 42 37 22 56 138 134 132 99
0 0 0 0 0 0 -15 -155 0
0 0 0 0 0 0 24 0 0
-1,026 -167 -86 -23 0 -62 -740 -4,686 -143
-1,499 -1,170 3,923 2,357 382 165 -167 148 -92
-1,889 -2,285 -1,539 -2,731 -5,715 -5,980 -5,193 2,376 -6,710
9 2 1 0 0 425 0 0 0
0 0 0 17,698 10,552 6,603 1,763 8,160 4,716
0 0 0 -16,807 -13,893 -10,802 -4,400 -3,030 -8,106
-301 -334 -477 -461 -272 -144 -73 -99 -219
-724 -243 -813 -1,326 -1,399 -1,586 -2,169 -2,520 -2,901
0 0 0 0 0 -118 -129 -135 -246
-872 -1,711 -250 -1,835 -702 -358 -186 0 46
848 611 -736 -844 -1,386 596 -1,765 115 4,735

You might also like